Immunosuppressive agents and infectious risk in transplantation: managing the “net state of immunosuppression”
MB Roberts, JA Fishman - Clinical Infectious Diseases, 2021 - academic.oup.com
Successful solid organ transplantation reflects meticulous attention to the details of
immunosuppression, balancing risks for graft rejection against risks for infection. The “net …
immunosuppression, balancing risks for graft rejection against risks for infection. The “net …
Cardiac xenotransplantation: from concept to clinic
B Reichart, DKC Cooper, M Längin… - Cardiovascular …, 2022 - academic.oup.com
For many patients with terminal/advanced cardiac failure, heart transplantation is the most
effective, durable treatment option, and offers the best prospects for a high quality of life. The …
effective, durable treatment option, and offers the best prospects for a high quality of life. The …
Human OX40L–CAR-Tregs target activated antigen-presenting cells and control T cell alloreactivity
Regulatory T cells (Tregs) make major contributions to immune homeostasis. Because Treg
dysfunction can lead to both allo-and autoimmunity, there is interest in correcting these …
dysfunction can lead to both allo-and autoimmunity, there is interest in correcting these …
Delivery of costimulatory blockade to lymph nodes promotes transplant acceptance in mice
The lymph node (LN) is the primary site of alloimmunity activation and regulation during
transplantation. Here, we investigated how fibroblastic reticular cells (FRCs) facilitate the …
transplantation. Here, we investigated how fibroblastic reticular cells (FRCs) facilitate the …
Pig-to-non-human primate heart transplantation: the final step toward clinical xenotransplantation?
B Reichart, M Längin, J Radan, M Mokelke… - The Journal of Heart and …, 2020 - Elsevier
Background The demand for donated human hearts far exceeds the number available.
Xenotransplantation of genetically modified porcine organs provides an alternative. In 2000 …
Xenotransplantation of genetically modified porcine organs provides an alternative. In 2000 …
[HTML][HTML] Corneal xenotransplantation: Where are we standing?
CH Yoon, HJ Choi, MK Kim - Progress in retinal and eye research, 2021 - Elsevier
The search for alternatives to allotransplants is driven by the shortage of corneal donors and
is demanding because of the limitations of the alternatives. Indeed, current progress in …
is demanding because of the limitations of the alternatives. Indeed, current progress in …
Pathways to clinical cardiac xenotransplantation
B Reichart, M Längin, J Denner, R Schwinzer… - …, 2021 - journals.lww.com
Heart transplantation is the only long-lasting lifesaving option for patients with terminal
cardiac failure. The number of available human organs is however far below the actual …
cardiac failure. The number of available human organs is however far below the actual …
Emerging new approaches in desensitization: targeted therapies for HLA sensitization
There is an urgent need for therapeutic interventions for desensitization and antibody-
mediated rejection (AMR) in sensitized patients with preformed or de novo donor-specific …
mediated rejection (AMR) in sensitized patients with preformed or de novo donor-specific …
[HTML][HTML] Neonatal islets from human PD-L1 transgenic pigs reduce immune cell activation and cellular rejection in humanized nonobese diabetic-scid IL2rγnull mice
Y Lei, L Wolf-van Buerck, M Honarpisheh… - American Journal of …, 2024 - Elsevier
Strong xenorejection limits the clinical application of porcine islet transplantation in type 1
diabetes. Targeting T cell-mediated rejection is one of the main approaches to improve long …
diabetes. Targeting T cell-mediated rejection is one of the main approaches to improve long …
Integrative multi-omics profiling in human decedents receiving pig heart xenografts
In a previous study, heart xenografts from 10-gene-edited pigs transplanted into two human
decedents did not show evidence of acute-onset cellular-or antibody-mediated rejection …
decedents did not show evidence of acute-onset cellular-or antibody-mediated rejection …